Pharmaceutical Industry Information Portal

HomeTagsRSV vaccine

All posts by tag

RSV vaccine

Pfizer expands RSV portfolio by acquiring ReViral for up to $525 million

Pfizer Inc. and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately...

Open Orphan awarded £5mln RSV challenge study contract

Open Orphan plc., announces that hVIVO, a subsidiary of Open Orphan, has signed a £5m respiratory syncytial virus (RSV) human challenge study contract with...

Moderna will produce its mRNA vaccines in Melbourne, Australia

Moderna, Inc., on Wednesday announced the finalization of a strategic partnership with the Australian Federal Government to establish a state-of-the-art, domestic mRNA vaccine manufacturing...

Bavarian Nordic opens potential Chinese market for RSV vaccine

Bavarian Nordic announced, that it has entered into an exclusive license and supply agreement with Nuance Pharma, a Shanghai-based specialty pharmaceutical company, on the...

GSK halts phase III vaccine trial of respiratory virus in pregnant women

GlaxoSmithKline, a science-led global healthcare company, on Monday announced that the Company has decided to stop enrolment and vaccination in trials evaluating its potential...

Moderna initiates phase 3 portion of pivotal trial for mRNA Respiratory Syncytial Virus vaccine candidate

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Data and Safety Monitoring Board (DSMB) for the RSV...
spot_img

Expert Articles

spot_img